Cite
MLA Citation
Els Tobback et al.. “Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.” International journal of infectious diseases, vol. 122, 2022, pp. 628–635. http://access.bl.uk/ark:/81055/vdc_100164414794.0x000026